ArticleHaematologica2021

Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies.

Roberto Mina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.